BCAB vs. OCEA

In the year-to-date period, BCAB achieves a -27.30% return, which is significantly higher than OCEA's -98.19% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for BioAtla, Inc. (BCAB) and Ocean Biomedical Inc. (OCEA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BCAB Sharpe Ratio is -0.78, which is comparable to the OCEA Sharpe Ratio of -0.66. The chart below compares the historical Sharpe Ratios of BCAB and OCEA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither BCAB nor OCEA has paid dividends to shareholders.

The maximum BCAB drawdown since its inception was -99.62%, roughly equal to the maximum OCEA drawdown of -99.95%. Use the drawdown chart below to compare losses from any high point for BCAB and OCEA. For additional features, visit the drawdowns tool.

The current volatility for BioAtla, Inc. (BCAB) is 32.19%, while Ocean Biomedical Inc. (OCEA) has a volatility of 113.89%. This indicates that BCAB experiences smaller price fluctuations and is considered to be less risky than OCEA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between BioAtla, Inc. and Ocean Biomedical Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.